Dynamic structural changes accompany production of dihydroxypropanesulfonate by sulfolactaldehyde reductase by Sharma, Mahima et al.
This is a repository copy of Dynamic structural changes accompany production of 
dihydroxypropanesulfonate by sulfolactaldehyde reductase.




Sharma, Mahima orcid.org/0000-0003-3960-2212, Abayakoon, Palika, Lingford, James P 
et al. (6 more authors) (2020) Dynamic structural changes accompany production of 






Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Subscriber access provided by UNIV OF YORK
is published by the American Chemical Society. 1155 Sixteenth Street N.W.,
Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the
course of their duties.
Article
Dynamic structural changes accompany the production of
dihydroxypropanesulfonate by sulfolactaldehyde reductase
Mahima Sharma, Palika Abayakoon, James P Lingford, Ruwan Epa, Alan John,
Yi Jin, Ethan D. Goddard-Borger, Gideon J. Davies, and Spencer J. Williams
ACS Catal., Just Accepted Manuscript • DOI: 10.1021/acscatal.9b04427 • Publication Date (Web): 30 Jan 2020
Downloaded from pubs.acs.org on February 5, 2020
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a service to the research community to expedite the dissemination
of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in
full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully
peer reviewed, but should not be considered the official version of record. They are citable by the
Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore,
the “Just Accepted” Web site may not include all articles that will be published in the journal. After
a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web
site and published as an ASAP article. Note that technical editing may introduce minor changes
to the manuscript text and/or graphics which could affect content, and all legal disclaimers and
ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or
consequences arising from the use of information contained in these “Just Accepted” manuscripts.
1
Dynamic Structural Changes Accompany the Production of 
Dihydroxypropanesulfonate by Sulfolactaldehyde 
Reductase
Mahima Sharma,† Palika Abayakoon,‡ James P. Lingford,§ Ruwan Epa,‡ Alan John,§ Yi Jin,†,¶ 
Ethan D. Goddard-Borger,*,§ Gideon J. Davies,*,† Spencer J. Williams*,‡
Author Affiliations
†York Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, 
YO10 5DD, U.K.
‡School of Chemistry and Bio21 Molecular Science and Biotechnology Institute and University 
of Melbourne, Parkville, Victoria 3010, Australia
§ACRF Chemical Biology Division, The Walter and Eliza Hall Institute of Medical Research, 
Parkville, Victoria 3010, Australia and Department of Medical Biology, University of 
Melbourne, Parkville, Victoria 3010, Australia
¶Current address: School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3A
*sjwill@unimelb.edu.au, goddard-borger.e@wehi.edu.au, gideon.davies@york.ac.uk 
Page 1 of 25
































































2,3-Dihydroxypropanesulfonate (DHPS) is a major sulfur species in the biosphere. One 
important route for the production of DHPS is sulfoglycolytic catabolism of 
sulfoquinovose (SQ) through the Embden-Meyerhof-Parnas (sulfo-EMP) pathway. SQ is a 
sulfonated carbohydrate present in plant and cyanobacterial sulfolipids (sulfoquinovosyl 
diacylglyceride and its metabolites) and is biosynthesised globally at a rate of around 10 billion 
tonnes per annum. The final step in the bacterial sulfo-EMP pathway involves reduction of 
sulfolactaldehyde (SLA) to DHPS, catalysed by an NADH-dependent SLA reductase. Based 
on conserved sequence motifs, we assign SLA reductase to the β-hydroxyacid 
dehydrogenase (β-HAD) family, an example of a β-HAD enzyme that acts on a sulfonic acid 
substrate, rather than a carboxylic acid. We report crystal structures of the SLA reductase 
YihU from E. coli K-12 in its apo and cofactor-bound states, as well as a ternary complex 
YihU•NADH•DHPS with the cofactor and product bound in the active site. Conformational 
flexibility observed in these structures, combined with kinetic studies, confirm a sequential 
mechanism and provide evidence for dynamic domain movements that occur during catalysis. 
The ternary complex structure reveals a conserved sulfonate pocket in SLA reductase that 
recognises the sulfonate oxygens through hydrogen bonding to Asn174, Ser178, and the 
backbone amide of Arg123, along with an ordered water molecule. This triad of residues 
distinguishes these enzymes from classical β-HADs that act on carboxylate substrates. A 
comparison of YihU crystal structures with close structural homologues within the β-HAD 
family highlights key differences in the overall domain organization and identifies a peptide 
sequence that is predictive of SLA reductase activity.
Keywords: sulfoglycolysis, X-ray crystallography, alkylsulfonate, NADH-dependent, 
reductase, three-dimensional structure, bisubstrate enzyme kinetics
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The biodegradation of organosulfur compounds within the biogeochemical sulfur cycle is 
crucial for recycling this essential macronutrient. 2,3-Dihydroxypropanesulfonate (DHPS) is 
an important intermediate in the biosulfur cycle and is produced globally on a significant scale 
from organosulfur precursors by plants, diatoms and bacteria. Bacteria produce DHPS by 
catabolism of the sulfosugar sulfoquinovose (SQ), which has an estimated annual production 
of 1010 tonnes, through the sulfoglycolysis pathway (Figure 1).1-2 DHPS is also a major species 
in sulfur fluxes through the marine web. Oceanic diatoms produce massive amounts of DHPS, 
presumably by deamination of cysteinolic acid,3-5 with production levels on par with the major 
marine organosulfur species dimethylsulfoniopropionate6,7 and dimethylsulfoxonium 
propionate.8 DHPS is the substrate for a range of bacterial biomineralization processes that 
cleave the carbon-sulfur bond to liberate inorganic sulfite,3 sulfate9 or sulfide,10 or that lead to 
assorted secondary metabolites.11  For instance, Desulfovibrio sp. strain DF1 from anaerobic 
sewage sludge converts DHPS to hydrogen sulfide,10 while Roseobacter in marine 
environments convert DHPS to bisulfite.12,13 To facilitate these processes, enzymes have 
evolved to catalyse the inversion of R-DHPS, which may represent the stereoisomer formed 
by deamination of cysteinolic acid, to S-DHPS.12  On the whole, the enzymes and pathways 
involved in the synthesis and degradation of this significant sulfur-containing metabolite have 
not been well studied.
 
The molecular cloning of the sulfoglycolytic Embden-Meyerhof-Parnas (sulfo-EMP) 
pathway responsible for catabolism of SQ in E. coli revealed that the final chemical step 
involved reduction of the C3-sulfonate sulfolactaldehyde (SLA) to DHPS by the NADH-
dependent reductase YihU, followed by export from the cell.1  YihU belongs to the β-
hydroxyacid dehydrogenase family (β-HADs), a group of enzymes that until the discovery of 
the SLA reductase activity of YihU were believed to act exclusively on 3-hydroxy carboxylic 
acid substrates, such as glycerate, 6-phosphogluconate, serine, D-phenylserine, 2-
(hydroxymethyl)glutarate and succinate semialdehyde (an earlier report anticipated this result 
by noting the YihU catalysed NADH-dependent oxidation of 3-hydroxypropanesulfonate).14 β-
HADs feature highly conserved structural folds and conserved sequence motifs for cofactor 
and substrate binding.15 β-HADs bind their substrates in a cleft formed between their two 
domains: an N-terminal Rossmann domain and an all-helical C-terminal dimerization domain. 
Recently, the 3D structure of a NADPH-dependent dehydrogenase (IsfD) that plays a role in 
nitrogen assimilation from taurine (aminoethyl sulfonate) was reported.16 IsfD belongs to the 
short-chain dehydrogenase/reductase family and catalyses the reduction of sulfoacetaldehyde 
(SA) to isethionate: this enzyme utilizes a Tyr-Arg-Gln motif to recognize the sulfonate group 
of these C2-organosulfonates. IsfD differs from β-HADs in its two-domain structural framework 
and contains an N-terminal Rossmann fold and a small C-terminal tail formed of two β-strands. 
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Another group of NADH-dependent SA reductases have been identified from Bilophila 
wadsworthia (SarD)17 and Bifidobacterium kashiwanohense (TauF)18 that belong to the metal-
dependent alcohol dehydrogenase superfamily.
 
In this work, we present a combined sequence, kinetic and structural study of SLA 
reductase (YihU) from E. coli str. K-12. Sequence analysis reveals YihU to be the first example 
of a β-HAD that acts on a sulfonic acid substrate and identifies a sequence motif conserved 
among SLA reductases. A biochemical assay established to assess the kinetic properties of 
YihU confirms that it is a dedicated SLA reductase, with no detectable activity on the 
analogous glycolytic intermediate glyceraldehyde-3-phosphate. We show that modified NADH 
analogues are inhibitors of YihU, and that the enzyme acts through a rapid equilibrium 
sequential mechanism. Finally, we present a series of 3-D X-ray structures of YihU in its apo 
form, in a binary complex with NADH, and in a ternary product-like complex, 
YihU•NADH•DHPS. The 3-D structures provide a structural basis for cofactor binding and 
sulfonate recognition and illuminate the dynamic structural changes that occur during 
catalysis. 
Results and Discussion
Sequence alignment reveals YihU belongs to the β-HAD family.  Alignment of the E. coli 
YihU sequence with that of characterized β-hydroxyacid dehydrogenases (β-HADs) reveals 
that it shares the four defining motifs that are collectively involved in cofactor-binding, 
substrate-binding and catalysis (Figure 2A).15 Motif-1 of β-HADs consists of 
GXXGXGXMGXXXAXNXXXXG and contains the dinucleotide cofactor binding residues; 
motif-2 consists of substrate-binding sequence DAPVSGGXXXAXXG; motif-3 consists of 
GXXGXGXXXKXXXN/Q, which contains the active site lysine and conserved Asn/Gln residue; 
and motif-4 derives from the C-terminal domain comprising KDLGXAXD sequence and shows 
a high degree of conservation among bacterial homologues. Examination of the sequence 
alignment of a phylogenetically-related putative SLA reductases (assigned based on context 
within gene clusters encoding the sulfo-EMP pathway) from a selection of alpha-, beta- and 
gammaproteobacteria along with other β-HADs including 3-hydroxyisobutyrate 
dehydrogenases, 2-hydroxymethylglutarate dehydrogenases, 2-hydroxyl-3-oxopropionate 
reductases, and tartronate semialdehyde reductases, shows that SLA reductases form a 
distinct sub-group within the β-HAD family. The sequence alignment reveals that the key 
differences in the YihU sequences lie within motif-2 where Gly122-Arg123-Thr124 replace the 
conserved Ser-Gly-Gly seen in β-HADs (Figure 2B). Based on these sequence alignments 
that reveal the putative SLA reductases form a distinct subgroup, we define an extended motif-
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2 [D/EVPVGRTXXXAXXG] as a ‘sulfonate substrate-binding motif’ common to all SLA 
reductases.
YihU SLA reductase does not reduce GAP and follows a rapid equilibrium sequential 
kinetic mechanism. Reaction rates for YihU catalysed conversion of racemic D/L-SLA19 to 
DHPS were measured by monitoring absorbance at 340 nm for enzymatic NADH oxidation to 
NAD+. By varying the concentration of D/L-SLA and keeping NADH constant (0.10 mM) or vice 
versa using constant D/L-SLA (5.00 mM), we could perform Michaelis-Menten kinetic analyses 
for the two substrates. Kinetic parameters were calculated for the concentration of D-SLA, 
assuming that L-SLA was not a substrate. Both NADH and SLA exhibited saturation kinetics, 
allowing calculation of kcat, KMapp and kcat/KMapp values under pseudo first order conditions 
(Figure 3A,B). At [NADH] = 0.1 mM, under conditions of varying [SLA] we determined KMapp = 
0.3 mM, kcat = 3.3 x 102 s-1, and kcat/KMapp = 1.09 x 103 mM-1 s-1. At [D-SLA] = 2.5 mM, under 
conditions of varying [NADH] we determined KMapp = 0.082 mM, kcat = 5.48 x 102 s-1, and 
kcat/KMapp = 6.72 x 103 mM-1 s-1 (for full data and associated errors see Table 1). No activity 
was observed for reduction of racemic glyceraldehyde phosphate (GAP)20 under similar 
conditions. GAP is produced from DHAP through the action of triose phosphate isomerase, 
and in the first step of lower glycolysis undergoes conversion to 1,3-bisphosphoglycerate by 
the action of GAP dehydrogenase (GADPH). The lack of activity of YihU on GAP prevents 
interference with this important glycolytic/gluconeogenic intermediate. Saito et al. reported that 
YihU catalyzes succinate semialdehyde reduction with kinetic parameters of Vmax = 0.20±0.04 
mmol min-1 mg-1 and KMapp = 4.3±1.2 mM (at 1 mM NADH),14 which we calculate equates to 
kcat/KMapp = 26±12 M-1 s-1. Thus, YihU exhibits a 42,000-fold greater catalytic efficiency for the 
reduction of SLA over SSA. Collectively, these data confirm that YihU is a dedicated SLA 
reductase.
Multi-substrate enzymes perform catalysis through two main mechanisms: the 
sequential (ternary complex) mechanism, in which both substrates must bind before a 
chemical step leading to product formation; or the ping-pong mechanism, in which one or more 
products are released prior to binding of all substrates. The Theorell-Chance mechanism is a 
special case in which there is a defined order of substrate association and product release 
without accumulation of a ternary complex. As SLA reductase has two substrates and two 
products, its molecularity is described as Bi-Bi. For β-HADs21 and other dehydrogenases,22,23 
a sequential Bi-Bi mechanism is often reported with the binding of the redox-active cofactor 
preceding localisation and binding of the substrate.
Page 6 of 25































































For a bisubstrate enzyme with substrates A and B, plotting 1/𝑣0 versus 1/[A] at various 
constant concentrations of substrate B or 1/𝑣0 versus 1/[B] at various constant concentrations 
of substrate A can indicate the mechanism of the reaction.24 For a ping-pong mechanism, 
plotting 1/𝑣0 versus 1/[A] affords a series of straight lines with slope of KM(A)/Vmax. In contrast, 
for a classical sequential mechanism plotting 1/𝑣0 versus 1/[A] will produce a family of straight 
lines with slope depending on the concentration of B that intersect to the left of the y-axis, or 
in the case of a rapid equilibrium sequential mechanism, on the y-axis.25 To study the kinetic 
mechanism used by YihU we simultaneously varied the concentration of SLA while NADH was 
held at saturation ([NADH] = 0.05-0.30 mM) and vice versa ([D/L-SLA] = 2.50-12.0 mM), at a 
constant concentration of YihU. The resulting double-reciprocal plots yielded patterns of lines 
that intersected on the y-axis (Figure 3C,D). For the plot of 1/[NADH] (at different SLA 
concentrations) the data intersected the y-axis above zero; for the plot of 1/[SLA] (at different 
NADH concentrations) the data clearly intersects on the origin. These patterns directly rule 
out a ping-pong mechanism for YihU. While intersection on the y-axis is unusual, it has been 
reported for creatine kinase by Schimerlik and Cleland, who derived the corresponding kinetic 
equations, and showed that the data could indicate which substrate bound first.25 In line with 
the analysis of Schimerlik and Cleland, the patterns observed here are consistent with a rapid 
equilibrium sequential mechanism, and indicate initial binding of NADH. The kinetic 
mechanism allows proposal of a catalytic mechanism for SLA reductases that is consistent 
with that proposed for other β-HADs and involves ordered binding of the two substrates NADH 
and SLA to form a ternary complex, followed by a chemical step involving hydride transfer 
from NADH and protonation of the substrate. 
We synthesized two NADH analogues by partial (tetrahydro-NADH) and complete 
reduction (hexahydro-NADH) of the nicotinamide ring of NADH, as described by Dave et al.26 
and assessed these compounds as inhibitors of YihU. Owing to the small amounts of these 
compounds available we limited our studies to determination of IC50 values. Under conditions 
of [SLA] = KM(SLA)/10 and [NADH] = KM(NADH) we measured IC50 values of 4.03 and 10.3 
mM, respectively (Figure S1). These data reveal that tetrahydro-NADH is a better inhibitor 
than hexahydro-NADH, as might be expected considering its greater structural resemblance 
to the cofactor. Disappointingly, we were unable to obtain X-ray structures of these inhibitors 
bound to YihU.
 
YihU forms a dimer of intimate homodimer pairs. In order to identify the amino acid 
residues involved in substrate binding and catalysis, we solved the X-ray structure of YihU. 
Despite conserved sequence motifs and moderate sequence similarity with other β-HADs, we 
could not achieve a structure solution using a single model. The YihU structure was solved 
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using the molecular replacement pipeline BALBES27 that selected a human 
hydroxyisobutyrate dehydrogenase as the reference structure (PDB ID 2GF2 with 31% 
sequence similarity). Data collection and refinement statistics for YihU structures are given in 
Table S1. YihU crystallised as a dimer of dimers with four molecules present in the asymmetric 
unit (Figure 4A). Size exclusion chromatography-multiangle light scattering (SEC-MALS) 
confirmed that YihU also exists as tetramer in solution (Figure S2). Within the asymmetric unit, 
each protomer adopts a two-domain architecture containing a N-terminal nucleotide binding 
domain (residues 1-164) and a C-terminal helical bundle (residues 165-294) both connected 
by long inter-domain helix α8 (Figure S3). The N-terminal domain is composed of a classical 
α/β Rossmann fold (comprised of an extended sheet formed of β1-6, flanked by α1-5 in a 
three-layered sandwich) appended with an additional β-α-β motif containing β7-9 and α6-7. 
An intimate homodimer pair between two monomers is formed through 3D domain swapping 
of the dimerization domains involving C-terminal helices α8-14. This dimerization domain is 
formed when the central trans-domain helix α8 from one monomer (A) inserts into the C-
terminal helical bundle from the opposite monomer (B) making several reciprocal interactions 
through both charged and hydrophobic residues (Figure S4). 
 
The tetrameric assembly and domain organization of YihU matches that of imine 
reductases (IREDs). Four interfaces are present within the subunits of the YihU tetramer: A-
B (Interfaces I and II), A-C (Interface III) and A-D (Interface IV) (Figure 4A, Figure S5). PISA 
analysis of the AB dimer assembly indicated a total buried surface area of 10,638 Å2. The 
interface area for chains A-B is 4,023 Å2, which corresponds to 38% of the total, indicating an 
intimate homodimer pair. At the major interface, interface I, the C-terminal bundle of subunit 
A (shown in grey) interacts with C-terminal domain of subunit B to form a hydrophobic helical 
core. Interface II also occurs in the AB dimer and harbours the active site formed by reciprocal 
domain sharing between C-terminal helices (A) and the N-terminal Rossmann domain of chain 
B, indicating that dimer assembly is essential for catalytic activity of YihU. Conserved residue 
Lys171 in motif-3 projects into an inter-domain cleft that is lined mainly by charged, polar 
residues (Table S2). Interfaces III and IV comprise minor interfaces and are formed by 
hydrogen bonding interactions between subunits A-C and A-D, respectively. These interfaces 
appear to be important for assembly of the tetramer and may contribute to the overall stability 
of the enzyme.
 
A DALI search using YihU against the RCSB PDB library revealed that its closest 
structural neighbours belong to the β-HAD family. The closest structural homologues included 
human 3-hydroxyisobutyrate dehydrogenase (PDB ID: 2GF2 with DALI z score of 
31.6, rmsd 2.2 and 31% sequence ID), tartronate semialdehyde reductase from Salmonella 
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typhimurium LT2 (1VPD28 with DALI z score of 31.5 and 32% sequence ID) and 6-
phosphogluconate dehydrogenase from Pyrobaculum calidifontis (3W6U29 with z score of 31.4 
and 31% sequence similarity). Several other annotated hydroxyisobutyrate dehydrogenases 
(HIBDHs) that have been reported to reduce imine substrates (imine reductases or IREDs) 
were also identified including 5OCM,30 5G6S,31 and 6EOD32 with low sequence identity (16-
20%) but relatively high DALI z scores of 25-27 and overall rmsd of 2.2-3.2, reflecting high 
structural similarities. Superposition of monomers of human HIBDH (2GF2) and the IRED from 
Streptosporangium roseum (5OCM) with YihU shows all three proteins contain a common 
two-domain structure comprising N-terminal Rossmann-like fold and C-terminal helical bundle 
connected by a long transdomain helix. However, while superposition of the isolated 
Rossmann domain and C-terminal helices of YihU monomer over the two domains of human 
HIBDH shows high fold conservation (RMSD 1.14Å/160 residues and 1.32Å/74 residues for 
N- and C-termini domains, respectively), the quaternary organization of the subunits display 
large differences. In human HIBDH, α9 helix of C-terminal domain takes a sharp turn to 
interact with N-terminal domain from the same monomer. As a result, the two monomers in 
human HIBDH sit adjacent to one another and only interact along the length of long α8 helix, 
arranged in a back-to-back fashion in a dimer pair (Figure 4B).  On the other hand, the two 
domains in YihU are rewired such that their subunit organization is similar to IREDs.33 YihU 
and IREDs possess homodimeric folds formed by extensive domain swapping. In YihU (or the 
equivalent helix in IREDs), helix α9 of monomer A adopts an extended conformation so that 
the C-terminal helices (of chain A) travel further away and form an active site cleft with the N-
terminal domain of opposite monomer B (Figure 4C, Figure S6).
A binary YihU•NADH complex reveals dynamic domain movement upon cofactor 
binding.  Co-crystallization of YihU with NADH afforded a binary complex showing clear 
density for the cofactor bound to the N-terminal Rossmann domain of all four monomers within 
the asymmetric unit (Figure 5A-B, Figure S7). Domain conformational motion analyses of the 
apo and YihU•NADH structures, using the DynDom program,34 reveals the former adopts an 
‘open’ and the latter a ‘closed’ conformation, as a result of two dynamic domains with a 
bending region comprised of residues 156-166 connecting the two domains. Cofactor binding 
results in an 8° inter-domain rotation to form a more compact active-site pocket that 
encapsulates the NADH molecule. The NADH molecule binds in a syn conformation and the 
2'-hydroxyl of ribose ring is hydrogen-bonded to Asp31, a residue that provides specificity for 
NADH. By contrast, NADPH binding β-HAD homologues possess Asn at this position, usually 
followed by an arginine residue that makes stacking interactions with adenine and binds to 2’-
phosphate of NADPH. The structure shows that NADH specificity likely arises from 
destabilizing interactions of Asp31 that would occur with the 2'-phosphate in NADPH. The 
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nicotinamide ring of NADH projects into a relatively narrow cleft formed as a result of domain 
closure upon binding of the cofactor. 
YihU possesses a defined substrate channel for entry of SLA to the active site.  Two 
pores that could possibly provide for entry of SLA into the active site (as defined by the location 
of the catalytic Lys171) were identified in the YihU-apo structure. However, upon binding of 
NADH to form the YihU•NADH complex, domain movement leads to closure of the active site, 
blocking one of these pores. At the entry to the other pore, Arg123 (chain A) and Lys213 (chain 
B) contribute to a positively charged surface patch which may facilitate entry of the negatively 
charged substrate SLA (Figure 5C). 
Using CAVER Web 1.0,35 a tool for visualization and analysis of tunnels and channels 
in protein structures, we selected Lys171 in the YihU•NADH structure as the reference starting 
point. A 10.4 Å long tunnel was visualised, which could provide a pathway for entry of the 
substrate SLA (and possibly release of the product DHPS). This tunnel tapers to a bottleneck 
at the back of the sulfonate-binding pocket to confine the dimensions of the substrate pocket 
(Figures S8-9). Thus, the residues forming the sulfonate binding pocket, the residues at the 
entry to this predicted tunnel, and its size may contribute to the substrate specificity of YihU, 
possibly involving electrostatic filtering of anionic substrates at the entrance to the tunnel 
(Table S2). 
A ternary YihU•NADH•DHPS complex reveals the sulfonate binding pocket and active 
site residues. A ternary complex was obtained with NADH and the product DHPS, by soaking 
solid racemic DHPS directly onto a YihU•NADH crystal in mother liquor. Close examination of 
the 3D structure revealed the two dimer pairs (comprised of four chains in the asymmetric unit) 
are present in different conformations with varying ligand densities observed close to 
Ser178/Asn174 in the active site cleft. The NADH cofactor was found to be somewhat mobile 
in the different chains in the structure upon soaking DHPS at high concentrations, resulting in 
apo conformations in two chains and a binary YihU•DHPS complex in one of the chains. In 
one monomer, clear density was seen for both the NADH cofactor and another ligand bound 
at the active site that allowed modelling of the natural isomer S-DHPS (Figure 6A). S-DHPS 
sits within the active site and is anchored to Lys171 by hydrogen-bonds to C-1 (2.5 Å) and 
C-2 (2.9 Å) hydroxyls, and flanked by bulky, hydrophobic residues on the other side (Phe233 
and Trp279 from the opposite subunit B). A well-ordered binding pocket surrounds the 
sulfonate group of S-DHPS. One sulfonate oxygen makes hydrogen bonds with Ser178 and 
Asn174 at 2.6 and 3.1 Å, respectively; the second oxygen is hydrogen-bonded to Asn174 (2.9 
Å) and the backbone amide N-H of Arg123 (2.9 Å); and the third sulfonate oxygen makes a 
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hydrogen bond with the bound water molecule (Figure 6B). This water molecule is 3 Å from 
the backbone amide of Ala210 (not a conserved residue) and at 2.7 Å and 3.3 Å distance from 
two ordered water molecules; one of these H-bonds to side-chain hydroxyl of Ser219. 
Crucially, this sulfonate binding triad of residues Arg123-Asn174-Ser178 is conserved in all 
assigned bacterial SLA reductases (Figure 2A). 
While S-DHPS is the product of the reaction, within the YihU•NADH•DHPS complex 
NADH and S-DHPS are positioned in what can be considered a catalytically relevant 
conformation, with C-1 of DHPS situated 3.3 Å away from C4 of nicotinamide ring. As D-SLA 
would make many of the same interactions as S-DHPS and NADH is seen bound in a syn 
conformation in our ternary complex, this confirms that reduction of SLA by NADH will involve 
transfer of hydride from the si-face of NADH (Figure 6C). 
Identification of the structural basis for binding of sulfonate and carboxylate substrates 
in the β-HAD family. In order to understand how sulfonate/carboxylate selectivity arises within 
the β-HAD family, we compared the structures of the YihU•NADH•DHPS complex and that of 
Salmonella typhimurium GarR-tartronate semialdehyde reductase bound to a substrate 
analog, L-tartrate.28 A key difference is visible within motif-2, which contains the substrate 
binding loop that interacts with the carboxylate/sulfonate groups of the ligands (Figure 7). In 
YihU, Arg123 within the triplet Gly122-Arg123-Thr124 interacts with one sulfonate oxygen, 
whereas in GarR the equivalent (and conserved among classical carboxylate β-HADs) 
Ser123-Gly124-Gly125 residues exhibit a 180° flip in the central glycine (possibly enabled by 
the conformationally flexible Cα backbone of the two glycines) allowing one carboxylate 
oxygen to bind the backbone amides of Gly124 and Gly125, present at 2.7 Å and 2.9 Å 
respectively, and the other carboxylate oxygen to hydrogen-bond to side-chain hydroxyl of 
Ser123 (2.6 Å). 
We used site-directed mutagenesis to explore the role of the sulfonate binding motif in the 
function of YihU. Amino acids in the triplet Gly122-Arg123-Thr124 were individually converted 
to the corresponding residue in GarR and Michaelis-Menten parameters of the resulting 
variant proteins were measured under pseudo-first order conditions (Figure S11). All mutant 
enzymes suffered a reduction of catalytic efficiency (kcat/KMapp). The change in kcat/KMapp for 
NADH at constant [SLA] for each of the mutants versus the wildtype was small, in the range 
of 3-12-fold reduction, consistent with the sites of mutation involving interaction with SLA 
(Table 1). Conversely, the change in kcat/KMapp for SLA at constant [NADH] for each of the 
mutants relative to wildtype was greater, comprising a 25-, 130- and 230-fold reduction for the 
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G122S, R123G and T124G mutants, respectively. For the three mutants, KMapp for SLA at 
constant [NADH] was increased versus wildtype. 
Conclusion
As the final step in the sulfo-EMP pathway, the NADH-dependent SLA reductase YihU is an 
important enzyme in sulfur cycling in the biosphere. Our data reveals that YihU acts 
specifically on SLA, supporting an exclusive role in the E. coli sulfo-EMP pathway in reduction 
of SLA to the excreted metabolite DHPS. Absence of activity on GAP shows that YihU is 
unlikely to interfere with lower glycolysis or gluconeogenesis. A previous study by Saito et al. 
using recombinant E. coli YihU revealed that this enzyme possessed succinate semialdehyde 
reductase activity,14 however, our data shows that it possesses a 42,000-fold preference for 
SLA in terms of kcat/KM. Indeed, since the sulfo-EMP gene cluster is overexpressed when E. 
coli is grown on SQ,1 reduction of SSA is not only catalytically insignificant but may also be 
physiologically unimportant. Interestingly, Saito et al. demonstrated that 3-
hydroxypropanesulfonate could be oxidized by YihU in the presence of NAD+.14 While 3-
hydroxypropanesulfonate is not a naturally occurring metabolite, it is the 2-deoxy analogue of 
DHPS and so this observation foreshadowed the subsequent discovery of the role of YihU in 
sulfoglycolysis. Our kinetic data demonstrates a rapid equilibrium sequential mechanism. The 
acquisition of YihU•NADH binary and YihU•NADH•DHPS ternary crystal complexes are 
consistent with a sequential mechanism involving initial binding of NADH. Binding of a 
sulfonate substrate occurs through a triad of conserved residues (Arg123-Asn174-Ser178) 
common to all putative SLA reductases. It is only known in one other case how enzymes in 
the sulfo-EMP pathway recognize a sulfonate group: 3-D structures of sulfoquinovosidases 
that catalyze hydrolysis of SQ glycosides revealed a highly conserved Tyr-Arg-Trp triad.36,37 
YihU possesses the four characteristic motifs that define members of the β-HAD 
family,15 and represents the first β-HAD that acts on a β-hydroxysulfonic acid, rather than a β-
hydroxycarboxylic acid. We identified an SLA-specific sequence DVPVGRT within motif-2 that 
distinguished putative SLA reductases from classical β-HADs. In the YihU•NADH•DHPS 
complex, a hydrogen bond between one of the sulfonate oxygens and the backbone N-H of 
Arg123 (within the triplet Gly122-Arg123-Thr124) appears particularly important. Conversely, 
in the case of tartronate reductase GarR, recognition of a carboxylate substrate is achieved 
by backbone chain flipping in the equivalent sequence triplet Ser123-Gly124-Gly125, resulting 
in a fundamentally different binding mode of the carboxylate involving side-chain hydrogen 
bonding with Ser123 and backbone N-H interactions with Gly124 and Gly125. Kinetic analysis 
of mutant enzymes created by converting each residue with the Gly122-Arg123-Thr124 triplet 
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of YihU to the corresponding residues in the Ser123-Gly124-Gly125 triplet of GarR are 
consistent with the roles of these residues in binding the sulfonate of SLA.
SLA reductases possess a close sequence relationship with hydroxyisobutyrate 
dehydrogenases (HIBDHs) within the β-HAD family. However, analysis of the domain 
arrangement seen in 3D X-ray structures highlights an alternative wiring pattern and a closer 
structural resemblance to imine reductases (IREDs), a sub-group of NADPH-dependent 
dehydrogenases that can reduce imines to amines. As seen in IREDs,30-33 extensive swapping 
of C-terminal helical bundles between the YihU protomers results in an active site formed at 
the inter-domain cleft of a dimer pair. Examination of monomeric (1VPD, a model β-HAD) and 
quaternary domain-swapped (YihU) conformations reveals that while consensus sequence 
motifs  and the overall monomer topology of β-HADs are retained, the substrate-binding motif-
2 and catalytic motif-3 from opposite monomer partners in the YihU dimer pair make H-
bonding interactions with the sulfonate and facilitate the binding of the natural substrate. 
Modelling allowed identification of a tunnel leading to the DHPS-binding subsite, and hint at a 
possible electrostatic gating mechanism for achieving substrate selectivity by positively 
charged surface residues (Arg123 and Lys213, also from opposite monomers) present at the 
tunnel entrance. 
Because SQ is a major organosulfur species produced by essentially all photosynthetic 
organisms, its biomineralization is a major contributor to the global sulfur cycle. As one of just 
two known pathways for catabolism of SQ (the other consisting of the sulfoglycolytic Entner-
Doudoroff pathway that leads to sulfolactate),38 the sulfo-EMP pathway is important for sulfur 
cycling and for production of DHPS for downstream biomineralization by other members of 
the bacterial community. The insights provided here into the kinetics, structure and function of 
SLA reductases deepen our understanding of this important arm of the biogeochemical sulfur 
cycle and will support future bioinformatic analysis of these enzymes.
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Figure 1. General pathways for cycling of sulfur from organosulfur sources via DHPS.  A, Sulfo-
EMP pathway in bacteria for degradation of SQDG to give S-DHPS. YihU-catalyzed reduction of SLA 
to DHPS is shown in blue. B, Degradative pathways for mineralization of sulfur from DHPS. 
Biosynthesis of DHPS by putative deamination of cysteinolic acid is likely catalysed by CoA/ComC 
homologues.
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Figure 2.  SLA reductases share β-HAD sequence motifs but possess a unique sulfonate 
substrate binding sequence. A, Sequence alignment of YihU with model β-HADs to show four 
consensus sequence motifs [motif 1 – cofactor binding GXXGXG sequence; motif 2 – substrate binding; 
motif 3 containing catalytic lysine; motif 4 – cofactor binding]. All four motifs are also conserved in YihU 
with the only differences in the substrate binding sequence highlighted in motif-2 residues: G122-R123-
T124. B, Phylogenetic tree showing relationship of SLA reductases (grey box) and β-hydroxy acid 
dehydrogenases (yellow box); consensus β-HAD sequence motifs for substrate binding motif-2 and 
catalytic motif-3 are indicated. SLA reductases form a separate sub-group with conserved ‘sulfonate 
substrate binding sequence’ at residues 122-124 (YihU numbering). Also highlighted is a clade 
comprised of other annotated β-HADs with predicted roles in sulfur metabolism (green box).  
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Figure 3. Kinetic studies and double reciprocal plots for rapid equilibrium sequential binding 
mechanism. A-B, Michaelis-Menten and Lineweaver-Burk (inset) plots for reduction of SLA to DHPS 
by YihU under pseudo first order conditions of [NADH] = 0.1 mM (for A) and [D-SLA] = 2.5 mM (for B). 
C-D, Double reciprocal plots indicate a rapid equilibrium sequential mechanism for YihU. D-SLA 
concentration was varied at several fixed concentrations of NADH (0.05–0.30 mM). D, NADH 
concentration was varied at several fixed concentrations of DL-SLA (2.5–12.0 mM).
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Figure 4. Domain organisation of YihU and comparison with HIBDHs and IREDs. A, Overall 
structure of YihU-apo depicted as dimer-of-dimers in different orientations (related by 90° rotation) to 
show interfaces I-IV. B-C, Representative dimer pairs from crystal structures of human HIBDH (2GF2) 
and the IRED from Streptosporangium roseum (5OCM) showing differences in domain organization 
between HIBDH vs. IRED/YihU enzymes. For each enzyme, the protomers from each dimer pair are 
depicted in different colours for clarity (in grey and gold or coral and blue).
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Figure 5. Dynamic domain movements revealed in the complex of YihU•NADH. A, Close-up of 
NADH bound to YihU. Backbone and carbon atoms of subunits A and B are shown in gold and grey, 
respectively, and NADH and DHPS are shown in cylinder format. Electron density corresponds to the 
2Fo − Fc and in blue at levels of 1.5σ. B, DynDom analysis of the dynamic domains and hinge bending 
motion of the YihU-apo (depicted in gold) vs. NADH bound conformation (in grey); the lines cross at the 
centre of rotation and the hinge axis is perpendicular to this crossing point. C, Electrostatic potential 
depiction of YihU-apo dimer surface showing positively charged patch on the surface gated by Arg123 
and Lys213. The ‘pore’ was visualized from surface to catalytic Lys171 in the active site (see Figure 
S9).
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Figure 6. Active site and mechanism of SLA reductase YihU. A, Ternary complex structure of YihU 
with NADH and DHPS bound at the active site showing the sulfonate pocket. Backbone and carbon 
atoms of subunits A and B are shown in gold and grey, respectively, and NADH and DHPS are shown 
in cylinder format. Electron density corresponds to the 2Fo − Fc map (in blue) at levels of 1.2σ. B, 
Detailed view of substrate binding pocket of YihU as observed in the ternary complex depicting 
hydrogen bonding interactions of DHPS with active site residues. C, Mechanism of SLA reductases 
proposed based on YihU•NADH•DHPS crystal structure showing hydride transfer from C4 of the si-face 
of the nicotinamide ring of NADH to the carbonyl of SLA, with lysine-171 as general acid residue. 
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Figure 7. Flexibility in structurally conserved β-HAD motifs provide distinct binding 
modes for carboxylate versus sulfonate substrates. A, Overlay of motifs 1-4 in the 
YihU•NADH•DHPS dimer pair (in gold and grey) and GarR•tartrate monomer (in grey). B, 
Close-up view of the substrate binding loop containing DAPVSGG in GarR and DVPVGRT 
sequence in YihU showing flip in backbone amides to bind the carboxylate substrate analog, 
L-tartrate. C, Comparison of carboxylate binding site in GarR•tartrate (1VPD) and sulfonate 
binding site in the YihU•NADH•DHPS structure. The NADH molecule is superposed here from 
the YihU•NADH•DHPS structure to illustrate the relative positioning of the cofactor in the 
GarR•tartrate structure.
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kcat (s-1) KMapp (mM) kcat/KMapp (mM-1 s-1)
YihU wildtype SLAa 332 ± 9 0.30 ± 0.038 1090 ± 120
NADHb 548 ± 28 0.082 ± 0.011 6720 ± 580
YihU-G122S SLAa 71 ± 2 1.63 ± 0.11 43 ± 4
NADHb 178 ± 9 0.123 ± 0.013 1450 ± 230
YihU-R123G SLAa 68 ± 6 7.99 ± 1.02 8.5 ± 1.8
NADHb 22.1 ± 0.5 0.009 ± 0.001 2360 ± 300
YihU-T124G SLAa 27 ± 2 5.74 ± 0.79 4.7 ± 1.0
NADHb 12.7 ± 0.6 0.023 ± 0.004 570 ± 130
a [SLA] was varied while [NADH] was held constant at 0.1 mM.
b [NADH] was varied while [SLA] was held constant at 5 mM.
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